Knockdown CKS2 can inhibit cell proliferation, induce cell cycle arrest, and increase the expression of P53, P21 and PTEN, suggesting that CKS2 may be biomarkers of NSCLC [20]. Here, TP53 is linked to non-small cell lung carcinoma.